Cycloserine’s mechanism of action

Cycloserine (Cycloserine) is an antibiotic used to treat tuberculosis, specifically multidrug-resistant tuberculosis (MDR-TB). Its mechanism of action is mainly to inhibit the growth and reproduction of Mycobacterium tuberculosis by interfering with the synthesis of bacterial cell walls. Below is the detailed mechanism of action of cycloserine.

Cycloserine competitively inhibits two key enzymes, namely alanine lysinase (alanine racemase) and D-alanine-D-alanine synthase (D-alanine-D-alanine ligase). These two enzymes play an important role in the synthesis of bacterial cell wall peptidoglycan (peptidoglycan). Alanine lysinase converts L-alanine into D-alanine, and D-alanine-D-Alanine synthase links two D-alanine molecules together to form D-alanine dipeptide, which is an important component of cell wall peptidoglycan.

By inhibiting these two enzymes, cycloserine effectively prevents the production of D-alanine and D-alanine dipeptides. This process is essential for bacteria to synthesize strong cell walls. Defects in the cell wall cause bacteria to lose their protective barrier, causing them to be unable to maintain normal physiological functions and structures, thereby inhibiting bacterial growth and reproduction.

Damage to the bacterial cell wall makes the bacteria fragile and susceptible to the influence of the external environment. Bacteria lacking an intact cell wall will undergo cell lysis (rupture of the cell membrane) in a highly osmotic environment, which in some cases may lead to bacterial death. Therefore, although cycloserine is primarily a bacteriostatic agent, it may also exhibit bactericidal effects under certain conditions.

Cycloserine's high selectivity against Mycobacterium tuberculosis gives it significant advantages in the treatment of tuberculosis, especially tuberculosis that is resistant to conventional first-line drugs such as isoniazid and rifampicin. Cycloserine provides an effective alternative for the treatment of tuberculosis through a unique mechanism of action, helping to control and eradicate drug-resistant Mycobacterium tuberculosis infections.

Cycloserine’s mechanism of action makes it an important component of multidrug-resistant tuberculosis treatment regimens. Used in combination with other anti-tuberculosis drugs, it can enhance the overall efficacy and reduce the risk of drug resistance. Understanding the mechanism of action of cycloserine will not only help optimize treatment options, but also provide an important reference for the development of new anti-tuberculosis drugs.